Home » Topics » Regulatory » Patents

Patents
RSS

Lilly's newest antipicornavirus agents

Sep. 27, 1996

Takeda discloses anti-Ureaplasma agents

Sep. 27, 1996

Bayer claims naphthyridine derivatives

Sep. 27, 1996

Sanofi reports tachykinin antagonists

Sep. 27, 1996

New tocolytics from Merck & Co.

Sep. 20, 1996

Another new use claimed for raloxifene

Sep. 20, 1996

Tulane U. investigates GHRH agonists

Sep. 20, 1996

Prokinetic macrolides reported by Abbott

Sep. 20, 1996

New agents for BPH from Abbott

Sep. 20, 1996

Merck & Co. continues to investigate 5alpha-reductase inhibitors

Sep. 20, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 14, 2025.
European VCs optimistic for med-tech exit opportunities in 2025
BioWorld MedTech
To say that European investors are optimistic about the outlook for the med-tech sector in 2025 is an understatement. A couple of companies are already listed on...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Feb. 14, 2025
European VCs bullish on med-tech investments in 2025
BioWorld MedTech
European companies looking for capital should find the fundraising environment more favorable in 2025. Private med-tech financings in January totaled about $2...
Kura/Kyowa Kirin’s ziftomenib hits phase II endpoints in AML
BioWorld
Kura Oncology Inc. and Kyowa Kirin Co. Ltd.’s selective oral menin inhibitor, ziftomenib, met the primary endpoints in the phase II registrational Komet-001 trial...